Viva Vaccine!

The world’s first Ebola vaccine was greenlit yesterday by the European Commission.

Over 250,000 people have already received the vaccine—donated by Merck—under a compassionate use protocol amid the DRC’s ongoing Ebola outbreak.

The vaccine—Ervebo—will now go through WHO’s prequalification process.

The EC has been looking to license a vaccine since the 2014 West Africa outbreak, which provided a rare opportunity for the vaccine to prove its efficacy.

The licensure is a massive victory for researchers who once wondered whether there was a market for such a vaccine.

“I think it’s a good day,” said lead researcher Heinz Feldmann.


Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top